Advertisement
MGTX vs VYGR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGTX is a Hold and VYGR is a Hold.
MGTX in downward trend: price dove below 50-day moving average on September 21, 2026
MGTX moved below its 50-day moving average on September 21, 2026 date and that indicates a change from an upward trend to a downward trend. In 52 of 57 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day moving average for MGTX crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MGTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for MGTX entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator entered the oversold zone -- be on the watch for MGTX's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 17 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where MGTX advanced for three days, in 220 of 261 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
MGTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 16 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 53 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. MGTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.950) is normal, around the industry mean (26.782). P/E Ratio (12.770) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (2.715) is also within normal values, averaging (437.542).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MGTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
VYGR in downward trend: 10-day moving average broke below 50-day moving average on September 17, 2026
The 10-day moving average for VYGR crossed bearishly below the 50-day moving average on September 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 89%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VYGR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for VYGR entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 17 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
VYGR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.078) is normal, around the industry mean (26.782). P/E Ratio (6.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.070) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (5.263) is also within normal values, averaging (437.542).
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. VYGR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VYGR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
MGTX | VYGR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 64 | 58 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 69 Overvalued | 55 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 16 | 98 | |
PRICE GROWTH RATING 1..100 | 63 | 91 | |
P/E GROWTH RATING 1..100 | 53 | 7 | |
SEASONALITY SCORE 1..100 | 85 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
VYGR's Valuation (55) in the Biotechnology industry is in the same range as MGTX (69). This means that VYGR’s stock grew similarly to MGTX’s over the last 12 months.
VYGR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MGTX (100). This means that VYGR’s stock grew similarly to MGTX’s over the last 12 months.
MGTX's SMR Rating (16) in the Biotechnology industry is significantly better than the same rating for VYGR (98). This means that MGTX’s stock grew significantly faster than VYGR’s over the last 12 months.
MGTX's Price Growth Rating (63) in the Biotechnology industry is in the same range as VYGR (91). This means that MGTX’s stock grew similarly to VYGR’s over the last 12 months.
VYGR's P/E Growth Rating (7) in the Biotechnology industry is somewhat better than the same rating for MGTX (53). This means that VYGR’s stock grew somewhat faster than MGTX’s over the last 12 months.
| MGTX | VYGR | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 83% | 1 day ago 74% |
| Stochastic ODDS (%) | 1 day ago 90% | 5 days ago 76% |
| Momentum ODDS (%) | N/A | N/A |
| MACD ODDS (%) | N/A | N/A |
| TrendWeek ODDS (%) | 1 day ago 82% | 1 day ago 86% |
| TrendMonth ODDS (%) | 1 day ago 82% | 1 day ago 84% |
| Advances ODDS (%) | 12 days ago 84% | N/A |
| Declines ODDS (%) | 3 days ago 82% | 3 days ago 82% |
| BollingerBands ODDS (%) | 1 day ago 80% | 1 day ago 86% |
| Aroon ODDS (%) | 1 day ago 80% | 1 day ago 72% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MGTX’s FA Score shows that 1 FA rating(s) are green while VYGR’s FA Score has 1 green FA rating(s).
- MGTX’s FA Score: 1 green, 4 red.
- VYGR’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MGTX’s TA Score shows that 4 TA indicator(s) are bullish while VYGR’s TA Score has 3 bullish TA indicator(s).
- MGTX’s TA Score: 4 bullish, 4 bearish.
- VYGR’s TA Score: 3 bullish, 3 bearish.
Price Growth
MGTX (@Biotechnology) experienced а -13.19% price change this week, while VYGR (@Biotechnology) price change was -22.45% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -10.78%. For the same industry, the average monthly price growth was -18.33%, and the average quarterly price growth was -21.56%.
Reported Earning Dates
MGTX is expected to report earnings on Nov 18, 2026.
VYGR is expected to report earnings on Nov 10, 2026.
Industries' Descriptions
@Biotechnology (-10.78% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PMFB | 27.75 | -0.02 | -0.07% |
| PGIM S&P 500 Max Buffer ETF - February (PMFB) | |||
| BHYB | 52.32 | -0.15 | -0.29% |
| Xtrackers USD High Yield BB-B ex Financials ETF (BHYB) | |||
| CVIE | 80.69 | -0.67 | -0.82% |
| Calvert International Responsible Index ETF (CVIE) | |||
| FTHF | 45.50 | -0.48 | -1.04% |
| First Trust Emerging Markets Human Flourishing ETF (FTHF) | |||
| CVRT | 43.26 | -1.24 | -2.78% |
| Calamos Convertible Equity Alternative ETF (CVRT) | |||
MGTX and
Correlation & Price change
A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with EDIT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then EDIT could also see price increases.
| Ticker / NAME | Correlation To MGTX | 1D Price Change % | ||
|---|---|---|---|---|
| MGTX | 100% | -6.17% | ||
| EDIT - MGTX | 54% Loosely correlated | -3.69% | ||
| SANA - MGTX | 53% Loosely correlated | -8.28% | ||
| TSHA - MGTX | 52% Loosely correlated | -2.95% | ||
| IMNM - MGTX | 49% Loosely correlated | -5.34% | ||
| VYGR - MGTX | 49% Loosely correlated | -7.77% | ||
More | ||||